JP2024546804A5 - - Google Patents
Info
- Publication number
- JP2024546804A5 JP2024546804A5 JP2024534718A JP2024534718A JP2024546804A5 JP 2024546804 A5 JP2024546804 A5 JP 2024546804A5 JP 2024534718 A JP2024534718 A JP 2024534718A JP 2024534718 A JP2024534718 A JP 2024534718A JP 2024546804 A5 JP2024546804 A5 JP 2024546804A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- composition
- amount
- sada
- approximately
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA202170621 | 2021-12-15 | ||
| DKPA202170621 | 2021-12-15 | ||
| PCT/DK2022/050279 WO2023110044A1 (en) | 2021-12-15 | 2022-12-14 | Formulations comprising a sada complex |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024546804A JP2024546804A (ja) | 2024-12-26 |
| JP2024546804A5 true JP2024546804A5 (enExample) | 2025-11-14 |
Family
ID=84547279
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024534718A Pending JP2024546804A (ja) | 2021-12-15 | 2022-12-14 | Ｓａｄａ複合体を含む製剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250041410A1 (enExample) |
| EP (1) | EP4448006A1 (enExample) |
| JP (1) | JP2024546804A (enExample) |
| KR (1) | KR20240124960A (enExample) |
| CN (1) | CN118382458A (enExample) |
| AU (1) | AU2022412918A1 (enExample) |
| CA (1) | CA3238361A1 (enExample) |
| TW (1) | TW202333794A (enExample) |
| WO (1) | WO2023110044A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3178510A1 (en) * | 2020-06-04 | 2021-12-09 | Ahmed Mahiuddin | Anti-b7h3 antibodies for the treatment of cancer |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010099536A2 (en) | 2009-02-27 | 2010-09-02 | Massachusetts Institute Of Technology | Engineered proteins with high affinity for dota chelates |
| AU2018261891B2 (en) | 2017-05-05 | 2024-11-21 | Memorial Sloan Kettering Cancer Center | Modular self assembly disassembly (SADA) technologies |
| ES3057687T3 (en) | 2017-07-06 | 2026-03-04 | Memorial Sloan Kettering Cancer Center | Dota-hapten compositions for anti-dota/anti-tumor antigen bispecific antibody pretargeted radioimmunotherapy |
| CA3136251A1 (en) * | 2019-04-08 | 2020-10-15 | Memorial Sloan Kettering Cancer Center | Cd19 antibodies and methods of using the same |
| CA3180445A1 (en) * | 2020-05-27 | 2021-12-02 | Brian H. SANTICH | Anti-gd2 sada conjugates and uses thereof |
| WO2022167052A1 (en) * | 2021-02-08 | 2022-08-11 | Y-Mabs Therapeutics, Inc. | Use of ascorbic acid as stabilizing agent for anti b7-h3 antibodies |
-
2022
- 2022-12-14 AU AU2022412918A patent/AU2022412918A1/en active Pending
- 2022-12-14 CN CN202280080939.6A patent/CN118382458A/zh active Pending
- 2022-12-14 TW TW111148054A patent/TW202333794A/zh unknown
- 2022-12-14 CA CA3238361A patent/CA3238361A1/en active Pending
- 2022-12-14 US US18/717,256 patent/US20250041410A1/en active Pending
- 2022-12-14 EP EP22826808.2A patent/EP4448006A1/en active Pending
- 2022-12-14 KR KR1020247023387A patent/KR20240124960A/ko active Pending
- 2022-12-14 WO PCT/DK2022/050279 patent/WO2023110044A1/en not_active Ceased
- 2022-12-14 JP JP2024534718A patent/JP2024546804A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004527525A5 (enExample) | ||
| ES2625145T3 (es) | Aplicación tópica y formulación de eritropoyetina para cicatrizar heridas cutáneas | |
| JP2020007356A5 (enExample) | ||
| JP2013531679A5 (enExample) | ||
| JP2018021007A5 (enExample) | ||
| JP2019533661A5 (enExample) | ||
| CA2443089A1 (en) | Antifungal suspension of micronized posaconazole | |
| JP2022166006A5 (enExample) | ||
| AU2022308121B2 (en) | Combination therapy for treatment of liver diseases | |
| JP2010513487A5 (enExample) | ||
| JP2019504086A5 (enExample) | ||
| JP2024546804A5 (enExample) | ||
| JP2005511642A5 (enExample) | ||
| RU2011122629A (ru) | Водная композиция, содержащая фолликулостимулирующий гормон | |
| CA2702431A1 (en) | Ready-to-use bivalirudin compositions | |
| JP2023552180A5 (enExample) | ||
| ES2244373T3 (es) | Emplasto de uso topico que contiene heparina y diclofenaco. | |
| JP5910354B2 (ja) | 口腔用組成物 | |
| JP2019535767A5 (enExample) | ||
| ES3035981T3 (en) | Long-term stable live microbiota composition | |
| CN101056623A (zh) | 稳定的头孢菌素衍生物冻干制剂 | |
| ES2732400T3 (es) | Suspensión aceitosa prolongada con perlas de recubrimiento entérico de omeprazol | |
| US20250032499A1 (en) | Methods of treating peripheral t-cell lymphoma | |
| JP2023536938A5 (enExample) | ||
| TW201008599A (en) | Formulations of canfosfamide and their preparation |